open access

Vol 3, No 3 (2010)
Conference report / Report
Published online: 2010-10-05
Get Citation

Terapia komórkowa ze szczególnym uwzględnieniem mobilizacji i pobierania komórek macierzystych do przeszczepienia

Jolanta Antoniewicz-Papis, Ryszard Pogłód, Elżbieta Lachert
Journal of Transfusion Medicine 2010;3(3):99-105.

open access

Vol 3, No 3 (2010)
SPRAWOZDANIA
Published online: 2010-10-05

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Terapia komórkowa ze szczególnym uwzględnieniem mobilizacji i pobierania komórek macierzystych do przeszczepienia

Journal

Journal of Transfusion Medicine

Issue

Vol 3, No 3 (2010)

Article type

Conference report / Report

Pages

99-105

Published online

2010-10-05

Bibliographic record

Journal of Transfusion Medicine 2010;3(3):99-105.

Authors

Jolanta Antoniewicz-Papis
Ryszard Pogłód
Elżbieta Lachert

References (17)
  1. Schlenke P, Mertens A, Ahlke C. How do I collect and process stem cells? ISBT Science Series. 2010; 5(n1): 136–140.
  2. Humpe A, Buwitt-Beckmann U, Gramatzki M. When do I (not) release cellular products? ISBT Science Series. 2010; 5(n1): 141–147.
  3. Richter E, Tapernon K, Friedrich AW, et al. Sterility testing of blood stem cell products is possible in the presence of 1 ml of a DMSO containing stem cell product. Vox Sanguinis. 2010; 99(supl. 1): P–1068.
  4. Pruss A, Mönig HJ. Current standards in tissue banking. ISBT Science Series. 2010; 5(n1): 148–154.
  5. Nikougoftar-Zarif M, Soleimani M, Abolghasemi H, et al. The effect of micro RNA-10A down regulation in megakaryocytic differentiation of umbilical cord blood CD133+ cells. Vox Sanguinis. 2010; 99(supl. 1): 6B-S49-02.
  6. Müller-Steinhardt H, Lauber S, Latta M. Evaluation of cryopreserved cord blood units after long-term storage, experience of the Mannheim Cord Blood Bank. Vox Sanguinis. 2010; 99(supl. 1): 6B-S49-03.
  7. Rebulla P, Giordano R. Regulation of cell based medicine, the European experience. The case of mesenchymal stem cell production for clinical application. Vox Sanguinis. 2010; 99(supl. 1): 5C-S39-02.
  8. Rojewski M, Dausend J, Schmidtke-Schrezenmeier G, et al. A standardized protocol from GMP compliant expansion of MSC from BM in an animal component free system. Vox Sanguinis. 2010; 99(supl. 1): 4C-S24-02.
  9. Xia W, Xu X, Fu Y, et al. Comparison of expansion culture conditions between the FCS and HPL in mesenchymal stem cells ex vivo. Vox Sanguinis. 2010; 99(supl. 1): P–1046.
  10. Peterbaurer-Scherb A, Hildner F, Aberl J, et al. Substitution of fetal calf serum by platelet lysate for culture of adipose derived stem cells. Vox Sanguinis. 2010; 99(supl. 1): P–1055.
  11. Leitner GC, Faschingbauer M, Fischer G, et al. Does administration of rh-GCSF to healthy volunteers induce epigenetic alteration in lymphocytes? Vox Sanguinis. 2010; 99(supl. 1): 3B-S05-02.
  12. Hölig K, Kramer M, Blechschmidt M, et al. Peripheral blood stem cell mobilization in healthy related donors — higher risk of mobilization failure? . Vox Sanguinis. 2010; 99(supl. 1): 3B-S05-04.
  13. Worel N, Rosskopf K, Agis H, et al. Plerixafor plus G-CSF can successfully mobilize CD34+ cells from patients who previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in Austria. Vox Sanguinis. 2010; 99(supl. 1): 3B-S05-04.
  14. Worel N, Agis H, et al. D’Addio A. The addition of Plerixafor can rescue PBSC after mobilization in patients with suboptimal CD34 counts after mobilization regimens with chemotherapy and G-CSF. Vox Sanguinis. 2010; 99(supl. 1): P–1082.
  15. Schrezenmeier H, Feldmann U, Ottinger H, et al. Stem cell transplantation (SCT) for non-malignant disorders: impact of stem cells source and donor type on outcome — analysis of the German registry for stem cell transplantation (DRST). Vox Sanguinis. 2010; 99(supl. 1): 3B-S05-03.
  16. Kreissig C, Fischer I, Voelker G. Prediction of CD34-cell counts in peripheral blood and stem cell products after G-CSF mobilization in unrelated donors. Vox Sanguinis. 2010; 99(supl. 1): P–1074.
  17. Wagner U, Wittmann G, Grützner S, et al. Enumeration of CD34+ hematopietic progenitor cells in leukapheresis products for transplantation: comparison of a dual-platform method with a single platform kit. Vox Sanguinis. 2010; 99(supl. 1): P–1055.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl